Delivering the
future of
personalized
medicine,
today.

Invoke Bio uses proprietary AI technology to develop 100% custom tailored immunotherapies for people living with cancer.

Our Technology

Each Tumor is Unique.
We Treat It That Way.

AI technology trained for heterogeneity. Our ML engine integrates multifaceted biomolecular signals, modeling tumor-immune interaction over time with best-in-class accuracy.

Greater target prediction accuracy translates directly into a stronger, more targeted immune response, better equipped to recognize and fight an individual's unique cancer.

Immunogenic Target Prediction Accuracy

10–30%
89%
Industry StandardInvoke Bio

3× more accurate than industry
and academic benchmarks

Used in world-leading medical centers

Stanford MedicineUC San Diego Moores Cancer Center

Backed by

Pear VCHCVCNFXIncite

Want to connect?

Whether you're a patient seeking access to our expanded access program, or a biopharma company, diagnostics firm, or research institution — we want to hear from you.